SUBSCRIBE
SUBSCRIBE

ReNAgade Therapeutics

NEWS
Pictured: Two business professionals in suits shaking hands
Deals
Orna Buys Competing RNA Biotech ReNAgade After Series A Financing
Orna Therapeutics announced Thursday it is acquiring ReNAgade Therapeutics, which launched in May 2023 with $300 million in Series A financing and is on BioSpace’s NextGen Class of 2024 startups to watch this year.
May 23, 2024
 · 
2 min read
 · 
Tyler Patchen
Pictured: A red illustration of a businessman walk
Business
C-Suite Shuffle: ReNAgade, Adaptimmune, Vittoria and More
Plus, last week Richard Gonzalez announced his retirement from AbbVie, PhRMA appointed Gilead’s O’Day to chair its board and Joseph Papa became president and CEO of Emergent.
February 28, 2024
 · 
5 min read
 · 
Neil Versel
A 3D rendering of a messenger RNA strand/iStock, l
Business
ReNAgade Launches with $300M to More Easily Deliver RNA Medicines
The Massachusetts-based startup’s goal is to develop RNA medicines that can treat diseases anywhere in the body using an “all-in-one” platform.
May 23, 2023
 · 
2 min read
 · 
Tristan Manalac
IN THE PRESS
Deals
Orna Therapeutics Announces Strategic Acquisition of ReNAgade Therapeutics to Solidify Leadership in Circular RNA Therapies
May 23, 2024
 · 
4 min read
Genetown
ReNAgade Therapeutics Continues Commitment to GanNA Bio and Glycan Biology
April 26, 2024
 · 
3 min read
Genetown
ReNAgade Therapeutics Announces Presentations at the ASGCT 27th Annual Meeting
April 22, 2024
 · 
3 min read
Business
ReNAgade Therapeutics Appoints Joe Bolen, Ph.D., Chief Science Innovation Officer
February 27, 2024
 · 
2 min read
Genetown
ReNAgade Therapeutics to Present at the Evercore ISI 2024 Emerging Biotech Conference
February 22, 2024
 · 
1 min read
Business
ReNAgade to Present at the Upcoming 42nd Annual J.P. Morgan Healthcare Conference
January 4, 2024
 · 
1 min read
Business
ReNAgade Therapeutics Appoints Paul Perreault to Board of Directors
December 5, 2023
 · 
2 min read
Genetown
ReNAgade Therapeutics to Present Preclinical Data Demonstrating Potent Extra-Hepatic Delivery of mRNA Using Proprietary Lipid Nanoparticles at 11th International mRNA Health Conference
October 30, 2023
 · 
2 min read
AWARDS
  • NextGen Badge - Brighspot Rework_NextGen - Class of 2024.jpg
JOBS